04:04 PM, 3rd Feb 2023
PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve the un-audited financial results for the quarter ended December 31 2022 subject to limited review by the Statutory Auditors of the Company.